Acambis Smallpox Vaccine Contract Could Carry 30% To 40% Profit Margins
Acambis foresees profit margins in the range of 30% to 40% from its contract with the Department of Health & Human Services to stockpile 155 mil. doses of smallpox vaccine
Acambis foresees profit margins in the range of 30% to 40% from its contract with the Department of Health & Human Services to stockpile 155 mil. doses of smallpox vaccine